PureTech’s Vedanta raises $27m for microbiome researchUS-based Vedanta Biosciences has raised $27 million in a Series C financing to investigate microbiome-derived therapies for several Share XPureTech’s Vedanta raises $27m for microbiome researchhttps://pharmaphorum.com/news/puretechs-vedanta-raises-27m-for-microbiome-research/
